News Tag: Other Corporate Information
-
Correction: The Board of Directors of Ortivus AB withdraws the proposal to the Annual General Meeting on 8 May 2025 regarding authorisation for the Board to issue shares, etc.
The Board of Directors of Ortivus AB has resolved to withdraw its proposal that the Board be granted authorisation by the Annual General Meeting to issue class B shares, etc. The proposal is withdrawn in its entirety.
-
We are pleased to welcome two new colleagues to Ortivus!
During February, we have strengthened our leadership team with Gabriel Åhbeck as Chief Technology Officer (CTO) and Emma Mattsson as Chief Marketing Officer (CMO). With Emma and Gabriel on board, we gain a powerful boost in our efforts towards innovation and growth within prehospital care.
-
The Implementation of MobiMed 5 and Integration with Cambio Cosmic in Region Norrbotten
Region Norrbotten has successfully trained all staff and launched the next-generation medical record system, MobiMed 5, replacing the previous system, Aweria.
-
Ortivus is extending its existing credit facility agreement with the company’s main shareholder, Ponderus Invest AB.
The credit facility amounts to 25 MSEK, all of which is currently utilized. The loan amount drawn under the facility carries a fixed annual interest rate of 8%.
